Women's Health Innovation Summit, Europe 2024

Women's Health Innovation Summit

Showcasing innovation, fuelling investment, and driving partnerships across Europe and Israel to improve the outcomes, access, and quality of healthcare for women.

Register Interest for 2024
Basel, Switzerland
16-17 April, 2024

Our 2024 Innovation Showcase will be announced soon! Check back for regular updates!

Thank you #WHISEU 2023!

After a successful first 2022 Summit, we were delighted to return to Switzerland to drive our mission of improving the access to and quality of healthcare for women across the globe. 

Whilst the distribution of FemTech companies in Europe currently sits at 27% (in comparison to North America’s 51%), there is the potential for huge growth in the market. Our event aims to act as the catalyst for this growth in the development of solutions in this underserved area. 

Our summit offered the opportunity for connection and partnership, bringing together the leaders and innovators from Europe and Israel, from large pharmaceutical companies and biotechs to start-ups, investors, and service providers, to collectively drive forward the women’s health market. 

As we are busy planning #WHISEU 2024, register your interest below to be the first to hear about Summit updates and registration!

We look forward to seeing you next year! 

Advisory Board

Author:

Gila Tolub

Partner
McKinsey & Company

Passionate about healthcare and its role in improving society, Gila advises CEOs and top teams at the leading life sciences companies on growth strategy, sustainability, Health Equity and organizational transformation. Gila also leads McKinsey's work with Healthcare Innovators in Israel supporting VC funds and CEOs in bringing healthcare innovation to market more quickly.

Gila Tolub

Partner
McKinsey & Company

Passionate about healthcare and its role in improving society, Gila advises CEOs and top teams at the leading life sciences companies on growth strategy, sustainability, Health Equity and organizational transformation. Gila also leads McKinsey's work with Healthcare Innovators in Israel supporting VC funds and CEOs in bringing healthcare innovation to market more quickly.

Author:

Jessica McCreadie

Principal
Octopus Ventures

Jess sits in the Health team, and her focus is engaging with, investing in and supporting Europe’s most promising health tech companies.

“The gap between health and life expectancy is widening and to improve quality of life in later years we need a more decentralised, preventative and personalised approach to healthcare.”

Prior to joining Octopus Ventures in June 2021, Jess led the health tech investing team at Legal & General supporting leading health innovations. She invested balance sheet capital into early-stage health tech businesses and supported scale up via board representation in her portfolio.

Earlier in her career Jess invested into and was a banker in a range of alternative asset classes including renewable energy, real estate, and Venture Capital Funds. Jess has a passion for sustainability and delivering social impact alongside economic value.

Outside of work Jess can be found enjoying London’s restaurants, cycling, running, trying out the newest fitness class on offer, or in the park running around with / after her dog.

Jessica McCreadie

Principal
Octopus Ventures

Jess sits in the Health team, and her focus is engaging with, investing in and supporting Europe’s most promising health tech companies.

“The gap between health and life expectancy is widening and to improve quality of life in later years we need a more decentralised, preventative and personalised approach to healthcare.”

Prior to joining Octopus Ventures in June 2021, Jess led the health tech investing team at Legal & General supporting leading health innovations. She invested balance sheet capital into early-stage health tech businesses and supported scale up via board representation in her portfolio.

Earlier in her career Jess invested into and was a banker in a range of alternative asset classes including renewable energy, real estate, and Venture Capital Funds. Jess has a passion for sustainability and delivering social impact alongside economic value.

Outside of work Jess can be found enjoying London’s restaurants, cycling, running, trying out the newest fitness class on offer, or in the park running around with / after her dog.

Author:

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt is the Founder & CEO at Femtech Insider, the number 1 source for all things femtech. The newsletter briefs people on deals, company and startup launches, as well as femtech and Healthtech industry insights. Alongside this, Kathrin is also the Co-Founder of PERLA Health, an evidence-based integrative approach towards changing the way that PCOS education and care are delivered.

Kathrin Folkendt

Founder & CEO, Co-Founder
Femtech Insider, Perla Health

Kathrin Folkendt is the Founder & CEO at Femtech Insider, the number 1 source for all things femtech. The newsletter briefs people on deals, company and startup launches, as well as femtech and Healthtech industry insights. Alongside this, Kathrin is also the Co-Founder of PERLA Health, an evidence-based integrative approach towards changing the way that PCOS education and care are delivered.

Author:

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

Keren Leshem, MBA

CEO
OCON Healthcare

Seasoned executive with over 20 years' experience in the medical device & pharmaceutical industries specializing in the management of innovative start-ups, strategy, commercialization, BD and financing.

Author:

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Author:

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

In the women’s health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.

 

Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.  

 

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

In the women’s health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.

 

Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.  

 

Author:

Lynae Brayboy

Chief Medical Officer
Clue

Lynae is the Chief Medical Officer at Clue, the company founded by Ida Tin who coined the term ‘femtech’. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it and was launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.

Lynae Brayboy

Chief Medical Officer
Clue

Lynae is the Chief Medical Officer at Clue, the company founded by Ida Tin who coined the term ‘femtech’. Clue’s mission is for women and people with cycles to make good choices for themselves, and live full lives not in spite of their biology, but in tune with it and was launched helloclue.com in February 2018 to help close the knowledge gap about the menstrual cycle—with information that’s accessible, serious, scientific, and empathetic.

Author:

Marija Butkovic

Founder & CEO
Women of Wearables

Marija Butkovic

Founder & CEO
Women of Wearables

Key statistics

350+
Attendees
40+
Speakers
15+
Dedicated Networking Hours
100+
Start-ups

AUDIENCE BREAKDOWN

Start Ups/ Femtech/ Entrepreneurs/ Innovation

We are committed to increasing exposure of emerging companies in women’s health, at all stages of growth and development, who are seeking partnership opportunities and are at the forefront of shaping the future of this space.

Pharma/ Medical Device & Diagnostics/Biotechs

At the forefront of innovation, big pharma, medical device, and biotech companies play a key role in shaping the investments and innovation happening in the women’s health sphere.

Investors/Funding Groups

We look to bring together leading investors with a particular focus in women’s health, ranging from seed, to angel, venture capital firms, private equity, funds, and advisors.

Non-profits/ Advocacy Groups

Non-profit organizations and advocacy groups play a key part in our Summits, and in the women’s health space in general, ensuring the fight towards health equity continues and awareness of the industry is being spread. 

Payors/Employers

Payers, insurance companies, and benefit providers provide an important bridge between stakeholders within the women’s health industry, and we are delighted to have more joining us at this years’ summit.

Service Providers

Industry support and service providers include advocacy groups, researchers, knowledge leaders and accelerators such as consultants, lawyers, CROs, non-profits and regulatory experts.

2023 Attendees Included

2023 Partners

Oncology Partner

Platinum Partners

Gold Partner

Event Partner

Start-Up Zone Partner

Care Package Partner

Media Partners

2023 Speakers

 

Marija Butkovic

Founder & CEO
Women of Wearables

Marija Butkovic

Founder & CEO
Women of Wearables

Marija Butkovic

Founder & CEO
Women of Wearables
 

Tania Boler

Founder & President
Elvie

Tania Boler

Founder & President
Elvie

Tania Boler

Founder & President
Elvie
 

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women

Alia El-Yassir

Regional Director for Europe and Central Asia
UN Women
 

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi

Founding Partner
Goddess Gaia Ventures

Priya Oberoi is the Founding Partner at Goddess Gaia Ventures, which is building a £100 million pre-series A venture fund to invest in companies innovating in women’s health and wellness. She is also the Founder and Managing Partner at Oberoi Capital Partners Limited. She is an avid angel investor and has over 20 years’ experience in the legal and financial industry and has a degree from Oxford University.

 

Valentina Sartori

Partner
McKinsey & Co

Valentina Sartori

Partner
McKinsey & Co

Valentina Sartori

Partner
McKinsey & Co
 

Chantal Cox

Early Stage Investor
Octopus Ventures

Chantal Cox

Early Stage Investor
Octopus Ventures

Chantal Cox

Early Stage Investor
Octopus Ventures
 

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore is the Co-Founder and Co-CEO at Peppy. A next-generation solution that’s transforming digital healthcare, working with employers and private medical insurers to give individuals physical, mental and emotional support when they need it most. Mridula has spent her career driving innovations in healthcare to make it more accessible and affordable. Most recently she has led commercial teams in the pharmaceuticals and digital health industries. Prior to that she was an engagement manager at McKinsey & Co.

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore

Co-Founder & Co-CEO
Peppy

Dr Mridula Pore is the Co-Founder and Co-CEO at Peppy. A next-generation solution that’s transforming digital healthcare, working with employers and private medical insurers to give individuals physical, mental and emotional support when they need it most. Mridula has spent her career driving innovations in healthcare to make it more accessible and affordable. Most recently she has led commercial teams in the pharmaceuticals and digital health industries. Prior to that she was an engagement manager at McKinsey & Co. She has a PhD in chemical engineering from MIT and an MBA from the MIT Sloan.

 

Valentina Milanova

Founder & CPO
Daye

Valentina Milanova is the founder of Daye, the gynae health research and development company on a mission to close the gender pain gap and overcome historical gender biases in medical research and product innovation. After years of research and testing, Daye launched its first consumer product in 2020 - the world‘s only cramp-soothing tampon.  From the outset, Valentina has baked her core values into the DNA of the company - Daye‘s products are created by women who used to be in the prison system, and their tampons are produced in a fully carbon neutral operation.

Valentina Milanova

Founder & CPO
Daye

Valentina Milanova

Founder & CPO
Daye

Valentina Milanova is the founder of Daye, the gynae health research and development company on a mission to close the gender pain gap and overcome historical gender biases in medical research and product innovation. After years of research and testing, Daye launched its first consumer product in 2020 - the world‘s only cramp-soothing tampon.  From the outset, Valentina has baked her core values into the DNA of the company - Daye‘s products are created by women who used to be in the prison system, and their tampons are produced in a fully carbon neutral operation. Born and raised in Bulgaria, Valentina moved to the UK to attend the University of Buckingham, where she got degrees in business, economics, and law.  After considering careers in journalism and econometrics, Valentina soon found herself drawn in by the start-up world, working first at Techstars and then as a venture associate for Founders Factory. Meanwhile, she began working on her own idea for a company. After 180 pitches to investors, Valentina managed to raise £4.23 million in seed funding and in 2018, Daye started officially changing the face of female health for the better.

 

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude

Peony Li

CEO & Founder
Jude
 

Shirley Sylvester

Therapeutic Area Medical Affairs Leader Infectious Diseases and Vaccines
Global Public Health, Johnson & Johnson

Shirley Sylvester

Therapeutic Area Medical Affairs Leader Infectious Diseases and Vaccines
Global Public Health, Johnson & Johnson

Shirley Sylvester

Therapeutic Area Medical Affairs Leader Infectious Diseases and Vaccines
Global Public Health, Johnson & Johnson
 

Jérôme Michaud

Business Partner
Innopearl

Jérôme Michaud

Business Partner
Innopearl

Jérôme Michaud

Business Partner
Innopearl
 

Veronika Horvath

Commercial Director
Forhercare

Veronika Horvath

Commercial Director
Forhercare

Veronika Horvath

Commercial Director
Forhercare
 

Peter Turek

Head of Women's Healthcare
Gedeon Richter

Peter Turek

Head of Women's Healthcare
Gedeon Richter

Peter Turek

Head of Women's Healthcare
Gedeon Richter
 

Mathieu Horras

CEO & Founder
Aspivix

Mathieu Horras

CEO & Founder
Aspivix

Mathieu Horras

CEO & Founder
Aspivix
 

Yotam Hod

CEO & Co-Founder
Gynica

Yotam Hod

CEO & Co-Founder
Gynica

Yotam Hod

CEO & Co-Founder
Gynica
 

Ipek Gunduz

Co-Founder & Partner
Bold Innovates

Ipek Gunduz

Co-Founder & Partner
Bold Innovates

Ipek Gunduz

Co-Founder & Partner
Bold Innovates
 

Melis Guvensoy Okalper

Board Member/Co-Founder & Partner
EIT Women/Bold Innovates

Melis Guvensoy Okalper

Board Member/Co-Founder & Partner
EIT Women/Bold Innovates

Melis Guvensoy Okalper

Board Member/Co-Founder & Partner
EIT Women/Bold Innovates
 

Ricarda Dewes

Business Lead
Wellster

Ricarda Dewes

Business Lead
Wellster

Ricarda Dewes

Business Lead
Wellster
 

Cecile Real

CEO & Co-Founder
Endodiag

Cecile Real

CEO & Co-Founder
Endodiag

Cecile Real

CEO & Co-Founder
Endodiag
 

Heloïse Nogues

FemTech Lead Program Manager
Station F

Heloïse Nogues

FemTech Lead Program Manager
Station F

Heloïse Nogues

FemTech Lead Program Manager
Station F
 

Issy Gordon

Healthcare Associate
Hambro Perks

Issy Gordon

Healthcare Associate
Hambro Perks

Issy Gordon

Healthcare Associate
Hambro Perks
 

Adam Amara

Co-Founder
Turing Biosystems

Adam Amara

Co-Founder
Turing Biosystems

Adam Amara

Co-Founder
Turing Biosystems
 

Nina Stanley

Chief Creative and Neuromarketing Officer
MODHealth

Nina Stanley

Chief Creative and Neuromarketing Officer
MODHealth

Nina Stanley

Chief Creative and Neuromarketing Officer
MODHealth
 

Ricarda Dewes

Business Lead
Wellster

Ricarda Dewes

Business Lead
Wellster

Ricarda Dewes

Business Lead
Wellster
 

Stasa Stankovic

PhD, Genomic Medicine
University of Cambridge

Stasa Stankovic

PhD, Genomic Medicine
University of Cambridge

Stasa Stankovic

PhD, Genomic Medicine
University of Cambridge
 

Nina Zoric

Associate
McKinsey & Co.

Nina Zoric

Associate
McKinsey & Co.

Nina Zoric

Associate
McKinsey & Co.
 

Axelle Ducos

Global Marketing Lead B2C, Population Health Management
Philips

Axelle Ducos

Global Marketing Lead B2C, Population Health Management
Philips

Axelle Ducos

Global Marketing Lead B2C, Population Health Management
Philips
 

Chris Payne

SVP
United Minds

Chris Payne

SVP
United Minds

Chris Payne

SVP
United Minds
 

Alison Slingsbury

Global Women’s Health Innovation Lead
Perrigo

Alison Slingsby is the Global Lead Women’s Health Innovation at Perrigo. Her main responsibilities are to uncover unmet needs and find appropriate new products and services to fill these gaps.

Alison’s career has been focused on Women’s Health for last 28 years, with her experience spanning across the various stages of a woman’s journey from contraception, fertility and through to menopause. Over her career Alison has been responsible for the launch of several new and innovative products.

Alison Slingsbury

Global Women’s Health Innovation Lead
Perrigo

Alison Slingsbury

Global Women’s Health Innovation Lead
Perrigo

Alison Slingsby is the Global Lead Women’s Health Innovation at Perrigo. Her main responsibilities are to uncover unmet needs and find appropriate new products and services to fill these gaps.

Alison’s career has been focused on Women’s Health for last 28 years, with her experience spanning across the various stages of a woman’s journey from contraception, fertility and through to menopause. Over her career Alison has been responsible for the launch of several new and innovative products.

At Perrigo we champion the right of women and people to determine their own sexual health journey and access the solutions they want. Alison is passionate to improve women’s lives through broadening access to solutions that really make a difference.

Alison is looking forward to networking and connecting with other like-minded professionals to continue on this journey.

 

Sara Rico

Customer Success Manager
Microsoft

Sara Rico

Customer Success Manager
Microsoft

Sara Rico

Customer Success Manager
Microsoft
 

Marco Rüedi, MD

Mentor, Tech4Eva, and Senior Business Coach
EPFL Innovation Park

Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management.

He is a strong believer in well-balanced teams: motivated to challenge the status quo! Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.

Marco Rüedi, MD

Mentor, Tech4Eva, and Senior Business Coach
EPFL Innovation Park

Marco Rüedi, MD

Mentor, Tech4Eva, and Senior Business Coach
EPFL Innovation Park

Marco is Entrepreneur, Coach and Trainer in the Swiss Start-up ecosystem with 20+ years international experience in strategic and operational roles across the LifeScience Industry and Healthcare Management.

He is a strong believer in well-balanced teams: motivated to challenge the status quo! Passionate to work with the next generation of Entrepreneurs/Managers for the challenges of tomorrow. He focused on Start-up and Innovation Management, Translational medicine. His motto is “From idea to market”.

He holds a Medical Doctor from the University of Fribourg, Berne and Zurich, an Executive Masters in Medical Management from eMMM PHW Bern, and an Executive Masters in Business Administration from eMBA PHW Bern.

 

 

Jeanne M. Schilder, MD

Global Medical Director, Breast & Gynaecologic Oncology
GSK

Jeanne M. Schilder, MD

Global Medical Director, Breast & Gynaecologic Oncology
GSK

Jeanne M. Schilder, MD

Global Medical Director, Breast & Gynaecologic Oncology
GSK
 

Marcel van Duin, PhD

Chief Scientific Officer
Organon

Marcel van Duin, PhD

Chief Scientific Officer
Organon

Marcel van Duin, PhD

Chief Scientific Officer
Organon
 

Gunita Bhasin

VC Investor
Unilever Ventures

Gunita Bhasin

VC Investor
Unilever Ventures

Gunita Bhasin

VC Investor
Unilever Ventures
 

Annie Theriault

Managing Partner
Cross Border Impact Ventures

Annie Thériault, Managing Partner at Cross-Border Impact Ventures (CBIV), an impact venture capital firm investing in women's, children's and adolescents' health technology companies addressing large international markets.  The firm focuses on four verticals, sexual and reproductive health, maternal, newborn and child health, general health and health infrastructure software with an emphasis on expanding access to world class technologies within North America and Europe as well as beyond to reach people living in emerging economies.  Throughout her career, Annie has been immersed in impact

Annie Theriault

Managing Partner
Cross Border Impact Ventures

Annie Theriault

Managing Partner
Cross Border Impact Ventures

Annie Thériault, Managing Partner at Cross-Border Impact Ventures (CBIV), an impact venture capital firm investing in women's, children's and adolescents' health technology companies addressing large international markets.  The firm focuses on four verticals, sexual and reproductive health, maternal, newborn and child health, general health and health infrastructure software with an emphasis on expanding access to world class technologies within North America and Europe as well as beyond to reach people living in emerging economies.  Throughout her career, Annie has been immersed in impact investing, venture capital, royalty financing, and capital markets.  Annie is a thought leader in the field of inclusive health technology investing with a gender and impact lens.  

Prior to founding CBIV, Annie worked with high impact companies to mobilize more than $100 million in non-dilutive capital as a venture capital investor and venture advisor. Annie was previously a director on the boards of several North American venture-backed companies, is an advisor to crowdfunding fintech company FrontFundr, and was previously Chief Investment Officer at Grand Challenges Canada. Annie obtained her PhD in Management from the Rotman School of Management at the University of Toronto, is a CFA Charterholder, and holds the ICD.D designation. She also has a master’s degree in Business Economics from Wilfrid Laurier University and a Bachelor of Science with First Class Honours in Chemistry from Mount Allison University.

 

Carina Roth

Investment Manager
Calm Storm Ventures

Carina Roth

Investment Manager
Calm Storm Ventures

Carina Roth

Investment Manager
Calm Storm Ventures
 

Lucy Baldwin

Principal Research & Strategy Consultant
Kinneir Dufort

Lucy Baldwin

Principal Research & Strategy Consultant
Kinneir Dufort

Lucy Baldwin

Principal Research & Strategy Consultant
Kinneir Dufort
 

Audrey Tsang

Co-CEO
Clue

Audrey Tsang

Co-CEO
Clue

Audrey Tsang

Co-CEO
Clue
 

Carrie Walter

Co-CEO
Clue

Carrie Walter

Co-CEO
Clue

Carrie Walter

Co-CEO
Clue
 

Madeleine Szeluch

ESG Director, Investor Relations
Novartis

Madeleine Szeluch

ESG Director, Investor Relations
Novartis

Madeleine Szeluch

ESG Director, Investor Relations
Novartis
 

Siwen Pan

Growth Equity Investor
Goldman Sachs

Siwen Pan

Growth Equity Investor
Goldman Sachs

Siwen Pan

Growth Equity Investor
Goldman Sachs
 

Eirini Rapti

Co-Founder & CEO
Inne

Eirini Rapti

Co-Founder & CEO
Inne

Eirini Rapti

Co-Founder & CEO
Inne
 

Michelle Tsai

VP Global Commercial Strategy
Myovant Sciences

Michelle Tsai

VP Global Commercial Strategy
Myovant Sciences

Michelle Tsai

VP Global Commercial Strategy
Myovant Sciences
 

Dirk Schneider

European Medical Affairs Lead, Immuno-oncology
GSK

Dirk Schneider

European Medical Affairs Lead, Immuno-oncology
GSK

Dirk Schneider

European Medical Affairs Lead, Immuno-oncology
GSK
 

Magdelena Plotcyzk, PhD

Investment Associate
MTIP

Magdelena Plotcyzk, PhD

Investment Associate
MTIP

Magdelena Plotcyzk, PhD

Investment Associate
MTIP
 

Diana Torgersen

Executive Director, External Innovation & Emerging Science
Organon

Diana Torgersen

Executive Director, External Innovation & Emerging Science
Organon

Diana Torgersen

Executive Director, External Innovation & Emerging Science
Organon
 

Danchen Zhao

Investment Director
MTIP

Danchen Zhao

Investment Director
MTIP

Danchen Zhao

Investment Director
MTIP
 

Caroline Noublanche

CEO
Apricity

Caroline Noublanche

CEO
Apricity

Caroline Noublanche

CEO
Apricity
 

Malin Riddarström

Head of Product Growth
Natural Cycles

Malin Riddarström

Head of Product Growth
Natural Cycles

Malin Riddarström

Head of Product Growth
Natural Cycles
 

Ruth Coleman

Venture Capital Investor
Mercia Asset Management

Ruth Coleman

Venture Capital Investor
Mercia Asset Management

Ruth Coleman

Venture Capital Investor
Mercia Asset Management
 

Emanuela Kufel

CEO & Co-Founder
Prosoma

Emanuela Kufel

CEO & Co-Founder
Prosoma

Emanuela Kufel

CEO & Co-Founder
Prosoma
 

Slava Rakov

Vice President Medical Affairs
Myovant Sciences

Slava Rakov

Vice President Medical Affairs
Myovant Sciences

Slava Rakov

Vice President Medical Affairs
Myovant Sciences
 

Eileen Burbidge

Founding Partner
Passion Capital

Eileen Burbidge

Founding Partner
Passion Capital

Eileen Burbidge

Founding Partner
Passion Capital

Register your interest for 2024

To discover our 2023 agenda and register your interest in the 2024 Summit, fill in your details on the right-hand side.


View the 2023 #WHISEU Agenda

Venue Description

Venue

Congress Center Basel Messepl. 21, 4058 Basel, Switzerland

The Congress Center Basel is the largest congress center in Switzerland in terms of area. Look forward to comfortable furnishings and the latest technology that meets even the highest demands.

To view a list of nearby hotels, please click here.

DISCOVER OUR MARKETING SOLUTIONS OPPORTUNITIES

Want to discover our bespoke marketing offerings?

View our Marketing Solutions Pack and learn more about our range of Lead Generation, Thought Leadership, Brand Awareness and Market Insight products.

View pack

Partner with Us

Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.

To discuss your objectives and partnership opportunities please contact [email protected]

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Other events you might be interested in:

Women's Healthy Aging Summit

Women's Health Innovation Summit 2023

Reproductive Health Innovation Summit